PEDIATRICS Vol. 66 No. 5 November 1980, pp. 725-729
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clyman, R. I.
Right arrow Articles by Mauray, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clyman, R. I.
Right arrow Articles by Mauray, F.

Circulating Prostaglandin E2 Concentrations and Incidence of Patent Ductus Arteriosus in Preterm Infants with Respiratory Distress Syndrome

Ronald I. Clyman MD1, Claire Brett MD1, and Françoise Mauray BS1

1 Department of Pediatrics, Mt Zion Medical Center, San Francisco, and Cardiovascular Research Institute and Department of Pediatrics, University of California, San Francisco

In several species prostaglandin E2 (PGE2) appears to be the most important prostanoid to regulate patency of the ductus arteriosus. We measured the arterial plasma concentration of PGE2 in 29 premature infants (17 with respiratory distress syndrome alone and 12 with respiratory distress syndrome and patent ductus arteriosus) to determine if there was an association between circulating PGE2 and patent ductus arteriosus. The PGE2 concentrations during the first two days after birth were higher than PGE2 concentrations after the third postnatal day (17.1 ± 3.1 pg/ml, mean ± SEM, n = 23, vs 6.12 ± 0.63 pg/ml, n = 19, P < .005). By the third postnatal day, arterial concentrations were similar to adult venous values. There was no significant difference between the plasma PGE2 concentrations in the 12 infants with patent ductus arteriosus and the concentrations in the 17 infants who had no signs of patent ductus arteriosus. These findings do not support the hypothesis that an increased concentration of circulating PGE2 is the primary cause for the persistent patency of the ductus arteriosus in preterm infants with respiratory distress syndrome.

Submitted on February 8, 1980
Accepted on April 24, 1980